Having trouble viewing this email? View in your browser.
Details on talks and posters you won’t want to miss



Discover QIAGEN solutions at ECCMID 2021

Infectious disease experts have experienced and learned a lot over the last year and half. This year at ECCMID we have prepared a virtual line-up discussing infectious disease testing now and in future. What is the role of multiplex testing? What can laboratories do to rapidly adjust to changing needs?

Check out our talk and posters details below and plan out your virtual visit to ECCMID 2021.

Jump to information on:

QIAGEN talks at ECCMID 2021

Details on ePosters

Meet our experts – schedule time with our booth experts to discuss all things diagnostic – syndromic testing, high-throughput and more. Talk to our team.

Attend our talks – Join us and our panel of experts as we look at the new normal in infectious disease testing


Syndromic testing symposium

Title: Syndromic diagnostics – better timing and better insights to improve patient care in COVID-19 and beyond.
Date/time: Monday, July 12 at 13:15

Add it to your calendar

Get more details


PCR testing in clinical microbiology symposium

Title: Enabling critical testing needs in clinical microbiology – innovative, random-access molecular diagnostic solutions to address pandemic and post- pandemic needs.
Date/time: Monday, July 12 at 16:15

Add it to your calendar

Get more details


Read the lastest research – check out the ePosters featuring innovative QIAGEN solutions as well and new products in development.


NeuMoDx ePosters

  • #4123 Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
  • #4030 Performance of an Automated In Vitro Diagnostic PCR Test for SARS-CoV-2 in Upper Respiratory Swabs and Saliva on the NeuMoDx Molecular System
  • # 4309 Performance Evaluation of a Novel Quantitative HIV-1 Assay on the Fully Automated NeuMoDx Molecular System

QIAstat-Dx ePosters

  • #3518 Preliminary clinical sensitivity analysis of the QIAstat-Dx Meningitis/Encephalitis Panel
  • #3063 Initial results show that the QIAstat-Dx Gastrointestinal Panel 2 differentiates Shiga-like toxin genes (stx1 and stx2) from diarrheagenic Shiga toxin-producing E. coli (EHEC/STEC) to aid diagnosing Typical Hemolytic Uremic Syndrome (HUS).
  • #1706 Research study: Tracking SARS-CoV-2 genome in search of nucleotide polymorphisms affecting QIAstat-Dx performance
  • #1716: Research study: Using QIAstat-Dx Respiratory SARS-CoV-2 Panel as a tool for diagnosis of zoonotic strains and the G4 EA avian-like H1N1 Influenza A and for differentiation from the seasonal Influenza A viruses

Follow the link below to get all of the details on QIAGEN’s ECCMID events. We look forward to seeing you virtually!


QIAGEN AT ECCMID 2021


Sample to Insight


 

Call us during our office hours (Monday to Friday):

800-426-8157

 
 

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit handbook. QIAGEN kit handbooks are available at www.qiagen.com or can be requested from QIAGEN Technical Services or your local distributor.

This advertisement was sent to michal.filipowski@qiagen.com by QIAGEN. If this email was forwarded to you and you‘d like to receive future communications and advertisements, please sign up here.

© 2021 QIAGEN. All rights reserved.

QIAGEN | QIAGEN Strasse 1 | 40724 Hilden | Germany
Commercial Register Düsseldorf (HRB 45822) | Managing Directors: Thierry Bernard, Roland Sackers, Dr. Barthold Piening

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe here.